These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 35428744)
21. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis. Chen J; Wang Z; Shen X; Cui X; Guo Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508 [TBL] [Abstract][Full Text] [Related]
22. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
23. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods. Liu J; Cheng Z Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248 [TBL] [Abstract][Full Text] [Related]
24. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis. Li F; Guo P; Dong K; Guo P; Wang H; Lv X J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342 [No Abstract] [Full Text] [Related]
25. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis. Chen B; Sun D; Qin X; Gao XH Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609 [TBL] [Abstract][Full Text] [Related]
26. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma. Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690 [TBL] [Abstract][Full Text] [Related]
27. Identification of Potential Genetic Biomarkers and Target Genes of Peri-Implantitis Using Bioinformatics Tools. Zhang X; Wang Z; Hu L; Shen X; Liu C Biomed Res Int; 2021; 2021():1759214. PubMed ID: 34931168 [TBL] [Abstract][Full Text] [Related]
28. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
29. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis. Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814 [TBL] [Abstract][Full Text] [Related]
30. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis. Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263 [TBL] [Abstract][Full Text] [Related]
31. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis. Yang HJ; Xue JM; Li J; Wan LH; Zhu YX Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600 [TBL] [Abstract][Full Text] [Related]
32. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis. Liu P; Li H; Liao C; Tang Y; Li M; Wang Z; Wu Q; Zhou Y PeerJ; 2022; 10():e12731. PubMed ID: 35178291 [TBL] [Abstract][Full Text] [Related]
33. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis. Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355 [TBL] [Abstract][Full Text] [Related]
34. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Shang M; Zhang L; Chen X; Zheng S Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587 [TBL] [Abstract][Full Text] [Related]
35. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
36. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer. Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328 [TBL] [Abstract][Full Text] [Related]
37. Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer. Huang H; Huang Q; Tang T; Zhou X; Gu L; Lu X; Liu F Med Sci Monit; 2019 Jun; 25():4333-4341. PubMed ID: 31181055 [TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. Wu B; Xi S BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849 [TBL] [Abstract][Full Text] [Related]
39. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Li D; Yin Y; He M; Wang J Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701 [TBL] [Abstract][Full Text] [Related]
40. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]